NBSE
NeuBase Therapeutics, Inc. Common Stock
NBSE
NBSE
Delisted
NBSE was delisted on the 10th of May, 2024.
24 hedge funds and large institutions have $371K invested in NeuBase Therapeutics, Inc. Common Stock in 2018 Q4 according to their latest regulatory filings, with 1 funds opening new positions, 5 increasing their positions, 8 reducing their positions, and 6 closing their positions.
New
Increased
Maintained
Reduced
Closed
less funds holding
Funds holding: →
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less capital invested
Capital invested by funds: $ → $
less first-time investments, than exits
New positions opened: | Existing positions closed:
Holders
24
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$38.1K | |
| 2 | +$14.5K | |
| 3 | +$7K | |
| 4 |
WS
Wedbush Securities
Los Angeles,
California
|
+$5.33K |
| 5 |
UBS Group
Zurich,
Switzerland
|
+$5.02K |
Top Sellers
| 1 | -$118K | |
| 2 | -$27.4K | |
| 3 | -$9K | |
| 4 |
VF
Virtu Financial
New York
|
-$5.21K |
| 5 |
BMCM
Bryn Mawr Capital Management
Philadelphia,
Pennsylvania
|
-$3K |